UCL  IRIS
Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at http://www.ucl.ac.uk/finance/research/post_award/post_award_contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
 More search options
Dr Reecha Sofat
Room 106
Rayne Building
5 Univeristy Street
London
UK
WC1E 6JJ
Appointment
  • Senior Lecturer Honorary Consultant
  • Metabolism & Experi Therapeutics
  • Div of Medicine
  • Faculty of Medical Sciences
Research Summary

Reecha Sofat is a Clinical Pharmacologist practising general internal medicine, cardiovascular risk and stroke as a sub-speciality.


Her group is interested in harnessing routinely collected health care data to improve quality and safety of care but also to be able to generate knowledge and hypotheses by linking this information to next generation –omics technologies. The aim is that this will improve outcomes not only for individuals but also will be of public health benefit. 

She is the PI of a group of studies, CORUM that aims to embed research into routine health care. By nature clinical care phenotypes patients and the sub-types of disease in great detail, be it through the written clinical record, routine blood tests and imaging that are carried out. Linked to next generation technologies including genomics, transcriptomics, proteomics and metabolomics these data could allow understanding aetiology of disease and specifically sub-types of disease. Moreover, because this research is embedded within the health care system, linking these data to the NHS number allows long term follow up and establishment of prognostic cohorts. The scale allows generation of knowledge that is of public health value and the focus on disease sub-types linked to next generation technologies allows precision medicine to become a reality. This framework will facilitate the next generation of randomised controlled trials for disease sub-types, but importantly by feeding this information back into the health care system it aims to improve the quality and safety of care of patients now and in the future. The first of the studies, SIGNUM, focuses on stroke. This is currently the highest recruiting study nationally. Other studies will focus on heart failure (CARDIUM), atrial fibrillation (ATRIUM), venous thromboembolism (COAGULUM) and conditions that may be related to vascular outcomes (VASCULARUM). These will open in early 2018.


By nature the work is multi-disciplinary and includes collaborations with clinical services and scientist, health care delivery organisations, epidemiologists, computational biology and engineering amongst others

Teaching Summary

She is the lead for the MBBS Uses of Medicines Spine at UCL, spanning undergraduate basic pharmacology teaching to clinical therapeutics teaching.

Academic Background
2006 MSc Master of Science – Epidemiology London School of Hygiene and Tropical Medicine
2001 MRCP Member of the Royal College of Physicians – Medicine Royal College of Physicians
1998 MBBS Bachelor of Medicine/Bachelor of Surgery – Medicine/Surgery University College London
1995 BSc Hons Bachelor of Science (Honours) – Neuroscience University of London
Please report any queries concerning the data shown on this page to https://www.ucl.ac.uk/hr/helpdesk/helpdesk_web_form.php
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by